Testing the Limits: Revisiting Standardized Testing in Pharmacy Education

Standardized tests have long served as tools in higher education admissions to assess academic readiness and predict student success. The Pharmacy College Admission Test (PCAT), established in 1974, historically played a crucial role in evaluating prospective student pharmacists. Research consistently linked higher PCAT scores with stronger academic performance in pharmacy programs. However, criticisms of standardized testing, such as biases against underrepresented and low-income students, prompted a shift toward test-optional policies in many institutions. The COVID-19 pandemic, along with a declining number of applicants, accelerated this trend and led numerous pharmacy schools to adopt PCAT-optional admissions policies, ultimately resulting in the examination’s official retirement in January 2024. This paradigm shift raises pertinent questions about the efficacy of current admissions practices amidst evolving educational landscapes marked by grade inflation, reliance on remote learning, and the use of generative artificial intelligence. Concurrently, other health professions, such as medicine and dentistry, continue to use standardized tests for admissions decisions. This commentary explores the impact of discontinuing standardized tests in pharmacy school admissions, highlighting challenges faced and proposing the development of a new, unbiased standardized assessment tool to aid in identifying students equipped to meet the demands of pharmacy education and practice.